Chris Baggett

Assistant Professor

University of North Carolina at Chapel Hill
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (21)

Background Population-based linked datasets are vital to generate catchment area and population health research. The novel Cancer Information and Population Health Resource (CIPHR) links statewide cancer registry data, public and private insurance claims, and provider- and area-level data, representing more than 80% of North Carolina’s large, diverse population of individuals diagnosed with cancer. This scoping review of articles that used CIPHR data characterizes the breadth of research generated and identifies further opportunities for population-based health research. Methods Articles published between January 2012 and August 2023 were categorized by cancer site and outcomes examined across the care continuum. Statistically significant associations between patient-, provider-, system-, and policy-level factors and outcomes were summarized. Results Among 51 articles, 42 reported results across 23 unique cancer sites and 13 aggregated across multiple sites. The most common outcomes examined were treatment initiation and/or adherence (n = 14), mortality or survival (n = 9), and health-care resource utilization (n = 9). Few articles focused on cancer recurrence (n = 1) or distance to care (n = 1) as outcomes. Many articles discussed racial, ethnic, geographic, and socioeconomic inequities in care. Conclusions These findings demonstrate the value of robust, longitudinal, linked, population-based databases to facilitate catchment area and population health research aimed at elucidating cancer risk factors, outcomes, care delivery trends, and inequities that warrant intervention and policy attention. Lessons learned from years of analytics using CIPHR highlight opportunities to explore less frequently studied cancers and outcomes, motivate equity-focused interventions, and inform development of similar resources.

Year:

2024

Background The University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center has developed a novel data resource, the Cancer Information and Population Health Resource (CIPHR), for conducting catchment area evaluation and cancer population health research that links the North Carolina Central Cancer Registry (NCCCR) to medical and pharmacy claims data from Medicare, Medicaid, and private plans operating within North Carolina. This study’s aim was to describe the CIPHR data and provide examples of potential cohorts available in those data. Methods We present the underlying populations included in the NCCCR and claims data before linkage and demonstrate estimated sample sizes when these data are linked and commonly used insurance enrollment criteria are applied. Results Data for the years 2003-2020 are present in CIPHR and include 947 977 cancer cases from the NCCCR and 21.6 million enrollees in public and private health insurance (cancer and noncancer cases). When limited to first or only cancers (n = 672 377), 86% could be linked to insurance enrollment for at least 1 month during 2003-2020 (n = 582 638), with 62% of individuals linking to enrollment during the month of cancer diagnosis. Among all registry cancer cases, 47% (n = 317 898) had continuous insurance enrollment for at least 12 months before and after cancer diagnosis. Conclusion CIPHR illustrates the utility of establishing and maintaining a statewide, comprehensive cancer population health database. This resource serves to characterize the cancer center catchment area and aids in tracking cancer outcomes and trends in care delivery as well as identifying disparities that require intervention and policy focus.

Year:

2024

Background: Rapid growth in the number of US cancer survivors drives the need for ongoing research efforts to improve outcomes and experiences after cancer. In this study, we describe the University of North Carolina (UNC) Cancer Survivorship Cohort, a medical center–based cohort of adults with cancer that integrates medical record–abstracted cancer information, patient-reported outcomes, and biological specimens. Methods: Participants ages 18+ were recruited from UNC oncology clinics between April 2010 and August 2016. After enrollment, participants completed questionnaires on a range of topics including demographics, health history, healthcare access and utilization, quality of life, and symptoms. Blood samples and tumor tissue specimens were collected and processed by study staff, and cancer characteristics and other clinical data were abstracted from electronic medical records. Participants consented to recontact for future studies and linkage of their data with other data resources. Results: In total, 3,999 participants with a cancer diagnosis were enrolled in the cohort. The most common cancer types among those enrolled included breast ( N = 866), uterine ( N = 458), colorectal ( N = 300), prostate ( N = 296), and head and neck ( N = 248) cancers. Blood specimens were collected for 3,027 participants (76%). Additional participants without cancer ( N = 1,299) were also enrolled, and the majority (62%) provided biospecimen samples. Conclusions: We encourage a wide collaboration with investigators across institutions seeking to advance research in cancer survivorship. Procedures are in place to support proposals for use of existing or linked data and for proposals that require participant recontact or analysis of biospecimens. Impact: The UNC Cancer Survivorship Cohort is a unique resource for cancer survivorship research.

Year:

2024

Supplementary Table 13 includes the two-year cumulative incidences for HCC surveillance overall and by insurance type, by calendar year of cirrhosis diagnosis, excluding individuals with decompensated cirrhosis (% and 95% confidence intervals).

Year:

2024

Supplementary Table 17 includes two-year cumulative incidences by cirrhosis etiology and by insurance, without imputing deaths for individuals insured through private insurance (% and 95% confidence intervals) (% and 95% confidence intervals).

Year:

2024

Background. Hepatocellular carcinoma surveillance is underutilized, with

Year:

2024

Supplementary Table 15 includes one-year cumulative incidences for HCC surveillance overall and by insurance type, by calendar year of cirrhosis diagnosis, without imputing deaths for individuals insured through private insurance (% and 95% confidence intervals).

Year:

2024

Supplementary Table 17 includes two-year cumulative incidences by cirrhosis etiology and by insurance, without imputing deaths for individuals insured through private insurance (% and 95% confidence intervals) (% and 95% confidence intervals).

Year:

2024

Supplementary Table 12 includes the one-year cumulative incidences for HCC surveillance overall and by insurance type, by calendar year of cirrhosis diagnosis, excluding individuals with decompensated cirrhosis (% and 95% confidence intervals).

Year:

2024

Supplementary Table 12 includes the one-year cumulative incidences for HCC surveillance overall and by insurance type, by calendar year of cirrhosis diagnosis, excluding individuals with decompensated cirrhosis (% and 95% confidence intervals).

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (15)

Paul Delamater

Assistant Professor

University of North Carolina

UNITED STATES
View details

Hung-Jui Tan

Assistant Professor

University of North Carolina

UNITED STATES
View details

Alfred Barritt

University of North Carolina

UNITED STATES
View details

Louise Henderson

Professor

University of North Carolina

UNITED STATES
View details

Jennifer L. Lund

University of North Carolina at Chapel Hill

UNITED STATES
View details

Andrew B. Smitherman

Associate Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Tomi Akinyemiju

Professor

Duke University

UNITED STATES
View details

Melissa A. Troester

Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Ronny Bell

Professor and Chair

UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

UNITED STATES
View details

Andrew Olshan

University of North Carolina at Chapel Hill

UNITED STATES
View details

Andrew M. Moon

Assistant Professor

University of North Carolina at Chapel Hill School of Medicine

UNITED STATES
View details

Clare Meernik

Research Assistant Professor

Texas Tech University Health Sciences Center

UNITED STATES
View details

Stephanie B. Wheeler

University of North Carolina at Chapel Hill

UNITED STATES
View details

Hazel B Nichols

Professor

University of North Carolina at Chapel Hill Gillings School of Global Public Health

UNITED STATES
View details

Erin Kent

Associate Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details